Inventor · disambiguated record
Eugene Maraskovsky
Also filed as: DOUGALL WILLIAM C · MARASKOVSKY EUGENE
15 granted patents·14 pending applications·439 citations·filing 1996–2023
94Inventor score
Top patents by PatentIndex Score
29 records- 0196US6537763B2Receptor activator of NF-κBIMMUNEX CORP·Filed 2001·Granted Mar 25, 2003·64 cites·12 claims
- 0295US6479635B1Receptor activator of NF-κBIMMUNEX CORP·Filed 2000·Granted Nov 12, 2002·55 cites·24 claims
- 0394US6649164B2Method for enhancing the functional capacity of dendritic cellsIMMUNEX CORP·Filed 2001·Granted Nov 18, 2003·37 cites·10 claims
- 0493US6528482B1Receptor activator of NF-κBIMMUNEX CORP·Filed 1999·Granted Mar 4, 2003·62 cites·10 claims
- 0590US6497876B1Method of stimulating an immune response with activated dendritic cellsIMMUNEX CORP·Filed 1999·Granted Dec 24, 2002·85 cites·15 claims
- 0687US8535669B2Methods of treating lupus by administering humanized anti-interleukin 3 receptor alpha chain antibodiesVAIRO GINO LUIGI·Filed 2011·Granted Sep 17, 2013·7 cites·17 claims
- 0787US6017527AActivated dendritic cells and methods for their activationIMMUNEX CORP·Filed 1996·Granted Jan 25, 2000·119 cites·15 claims
- 0885US9758585B2Compositions and methods for targeting type 1 interferon producing cellsCSL LTD·Filed 2015·Granted Sep 12, 2017·2 cites·16 claims
- 0985US2024226286A1Anti-tumor compositions and uses thereofCSL LTD·Filed 2023·Application pending·0 cites
- 1077US8569456B2Receptor activator of NF-kappaBANDERSON DIRK M·Filed 2012·Granted Oct 29, 2013·1 cites·4 claims
- 1172US2020030440A1Financial MethodCSL LTD·Filed 2018·Application pending·0 cites
- 1272US2015037374A1Anti-tumor compositions and uses thereofCSL LTD·Filed 2014·Application pending·0 cites
- 1371US2021252136A1Anti-tumor compositions and uses thereofCSL LTD·Filed 2020·Application pending·0 cites
- 1468US7150992B1Methods of preparing dendritic cells with flt3-ligand and antigenINNUNEX CORP·Filed 2000·Granted Dec 19, 2006·4 cites·5 claims
- 1568US2009075886A1Dendritic cell stimulatory factorIMMUNEX CORP·Filed 2008·Application pending·0 cites
- 1667US2014178364A1Compositions and methods for targeting type 1 interferon producing cellsCSL LTD·Filed 2013·Application pending·0 cites
- 1765US2017014507A1Anti-tumor compositions and uses thereofCSL LTD·Filed 2016·Application pending·0 cites
- 1863US8920803B2Immunotherapeutic method involving CD123 (IL-3Rα) antibodies and immunostimulating complexDRANE DEBRA PAULINE·Filed 2011·Granted Dec 30, 2014·3 cites·18 claims
- 1961US2004037845A1Use of flt3-ligand in the treatment of infectionFiled 2003·Application pending·0 cites
- 2059US2021292411A1Method of treating cancerCSL LTD·Filed 2020·Application pending·0 cites
- 2154US2016376364A1Method of treating cancerCSL LTD·Filed 2014·Application pending·0 cites
- 2252US9352038B2Treatment of neurological conditionsCSL LTD·Filed 2014·Granted May 31, 2016·0 cites·7 claims
- 2352US9211329B2Method of treating inflammatory bowel diseaseCSL LTD·Filed 2012·Granted Dec 15, 2015·0 cites·10 claims
- 2450US2003077263A1Method of activating dendritic cellsIMMUNEX CORP·Filed 2002·Application pending·0 cites
- 2547US2019023783A1Method of treating cancerCSL LTD·Filed 2018·Application pending·0 cites
- 2645US2010279409A1Method for modifying celluar immune resonse by modulating activin activityROBSON NEIL·Filed 2008·Application pending·0 cites
- 2744US11141466B2Modulation of FVIII immunogenicity by truncated VWFCSL Behring Lengnau AG·Filed 2018·Granted Oct 12, 2021·0 cites·20 claims
- 2838US9364534B2Treatment of neurological conditionsMCKENZIE BRENT STEVEN·Filed 2010·Granted Jun 14, 2016·0 cites·7 claims
- 2929US2002034517A1Dendritic cell stimulatory factorFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eugene Maraskovsky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →